Literature DB >> 23261637

Reduced limbic metabolism and fronto-cortical volume in rats vulnerable to alcohol addiction.

Alessandro Gozzi1, Federica Agosta, Maurizio Massi, Roberto Ciccocioppo, Angelo Bifone.   

Abstract

Alcohol abuse is associated with long-term reductions in fronto-cortical volume and limbic metabolism. However, an unanswered question in alcohol research is whether these alterations are the sole consequence of chronic alcohol use, or contain heritable contributions reflecting biological propensity toward ethanol addiction. Animal models of genetic predisposition to alcohol dependence can be used to investigate the role of inborn brain abnormalities in the aetiology of alcoholism. Here we used magnetic resonance imaging (MRI) in the Marchigian-Sardinian (msP) alcohol-preferring rats to assess the presence of inherited structural or functional brain alterations. Alcohol-naïve msP (N=22) and control rats (N=26) were subjected to basal cerebral blood volume (bCBV) mapping followed by voxel-based morphometry (VBM) of grey matter and tract-based spatial statistics mapping of white matter fractional anisotropy. msP rats exhibited significantly reduced bCBV, an established marker of resting brain function, in focal cortico-limbic and thalamic areas, together with reduced grey matter volume in the thalamus, ventral tegmental area, insular and cingulate cortex. No statistically significant differences in fractional anisotropy were observed between groups. These findings highlight the presence of inborn grey matter and metabolic abnormalities in alcohol-naïve msP rats, the localization and sign of which are remarkably similar to those mapped in abstinent alcoholics and subjects at high risk for alcohol dependence. Collectively, these results point for a significant role of heritable neurofunctional brain alterations in biological propensity toward ethanol addiction, and support the translational use of advanced imaging methods to describe the circuital determinants of vulnerability to drug addiction.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23261637      PMCID: PMC4108793          DOI: 10.1016/j.neuroimage.2012.12.015

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  77 in total

1.  Nonparametric permutation tests for functional neuroimaging: a primer with examples.

Authors:  Thomas E Nichols; Andrew P Holmes
Journal:  Hum Brain Mapp       Date:  2002-01       Impact factor: 5.038

2.  Cortical gray matter loss in treatment-naïve alcohol dependent individuals.

Authors:  G Fein; V Di Sclafani; V A Cardenas; H Goldmann; M Tolou-Shams; D J Meyerhoff
Journal:  Alcohol Clin Exp Res       Date:  2002-04       Impact factor: 3.455

3.  Validation of nonrigid image registration using finite-element methods: application to breast MR images.

Authors:  Julia A Schnabel; Christine Tanner; Andy D Castellano-Smith; Andreas Degenhard; Martin O Leach; D Rodney Hose; Derek L G Hill; David J Hawkes
Journal:  IEEE Trans Med Imaging       Date:  2003-02       Impact factor: 10.048

4.  Improved optimization for the robust and accurate linear registration and motion correction of brain images.

Authors:  Mark Jenkinson; Peter Bannister; Michael Brady; Stephen Smith
Journal:  Neuroimage       Date:  2002-10       Impact factor: 6.556

5.  Genetic contributions to regional variability in human brain structure: methods and preliminary results.

Authors:  I C Wright; P Sham; R M Murray; D R Weinberger; E T Bullmore
Journal:  Neuroimage       Date:  2002-09       Impact factor: 6.556

Review 6.  Neuroadaptive mechanisms of addiction: studies on the extended amygdala.

Authors:  George F Koob
Journal:  Eur Neuropsychopharmacol       Date:  2003-12       Impact factor: 4.600

7.  Functional MRI using intravascular contrast agents: detrending of the relative cerebrovascular (rCBV) time course.

Authors:  Adam J Schwarz; Torsten Reese; Alessandro Gozzi; Angelo Bifone
Journal:  Magn Reson Imaging       Date:  2003-12       Impact factor: 2.546

8.  Neural response to alcohol stimuli in adolescents with alcohol use disorder.

Authors:  Susan F Tapert; Erick H Cheung; Gregory G Brown; Lawrence R Frank; Martin P Paulus; Alecia D Schweinsburg; M J Meloy; Sandra A Brown
Journal:  Arch Gen Psychiatry       Date:  2003-07

Review 9.  In vivo imaging of anaesthetic action in humans: approaches with positron emission tomography (PET) and functional magnetic resonance imaging (fMRI).

Authors:  W Heinke; C Schwarzbauer
Journal:  Br J Anaesth       Date:  2002-07       Impact factor: 9.166

10.  Assessment of halothane and sevoflurane anesthesia in spontaneously breathing rats.

Authors:  Michele A Steffey; Robert J Brosnan; Eugene P Steffey
Journal:  Am J Vet Res       Date:  2003-04       Impact factor: 1.156

View more
  19 in total

1.  Neurokinin 1 receptor blockade in the medial amygdala attenuates alcohol drinking in rats with innate anxiety but not in Wistar rats.

Authors:  Lydia O Ayanwuyi; Serena Stopponi; Massimo Ubaldi; Andrea Cippitelli; Cinzia Nasuti; Ruslan Damadzic; Markus Heilig; Jesse Schank; Kejun Cheng; Kenner C Rice; Roberto Ciccocioppo
Journal:  Br J Pharmacol       Date:  2015-10-22       Impact factor: 8.739

Review 2.  Building better strategies to develop new medications in Alcohol Use Disorder: Learning from past success and failure to shape a brighter future.

Authors:  Nazzareno Cannella; Massimo Ubaldi; Alessio Masi; Massimo Bramucci; Marisa Roberto; Angelo Bifone; Roberto Ciccocioppo
Journal:  Neurosci Biobehav Rev       Date:  2019-05-18       Impact factor: 8.989

3.  Neuropeptide S differently modulates alcohol-related behaviors in alcohol-preferring and non-preferring rats.

Authors:  Nazzareno Cannella; Marsida Kallupi; Hong Wu Li; Serena Stopponi; Carlo Cifani; Roberto Ciccocioppo; Massimo Ubaldi
Journal:  Psychopharmacology (Berl)       Date:  2016-05-28       Impact factor: 4.530

4.  MT-7716, a potent NOP receptor agonist, preferentially reduces ethanol seeking and reinforcement in post-dependent rats.

Authors:  Giordano de Guglielmo; Rémi Martin-Fardon; Koji Teshima; Roberto Ciccocioppo; Friedbert Weiss
Journal:  Addict Biol       Date:  2014-06-16       Impact factor: 4.280

5.  Decreased subcortical volumes in alcohol dependent individuals: effect of polysubstance use disorder.

Authors:  Erica N Grodin; Reza Momenan
Journal:  Addict Biol       Date:  2016-06-23       Impact factor: 4.280

6.  Rat strain differences in brain structure and neurochemistry in response to binge alcohol.

Authors:  Natalie M Zahr; Dirk Mayer; Torsten Rohlfing; Oliver Hsu; Shara Vinco; Juan Orduna; Richard Luong; Richard L Bell; Edith V Sullivan; Adolf Pfefferbaum
Journal:  Psychopharmacology (Berl)       Date:  2013-09-13       Impact factor: 4.530

Review 7.  Translational approach to develop novel medications on alcohol addiction: focus on neuropeptides.

Authors:  Massimo Ubaldi; Angelo Bifone; Roberto Ciccocioppo
Journal:  Curr Opin Neurobiol       Date:  2013-05-03       Impact factor: 6.627

Review 8.  Genetically selected alcohol-preferring msP rats to study alcohol use disorder: Anything lost in translation?

Authors:  Anna Maria Borruto; Serena Stopponi; Hongwu Li; Friedbert Weiss; Marisa Roberto; Roberto Ciccocioppo
Journal:  Neuropharmacology       Date:  2021-01-18       Impact factor: 5.273

9.  Functional Magnetic Resonance Imaging of Rats with Experimental Autoimmune Encephalomyelitis Reveals Brain Cortex Remodeling.

Authors:  Stefano Tambalo; Luca Peruzzotti-Jametti; Roberta Rigolio; Silvia Fiorini; Pietro Bontempi; Giulia Mallucci; Beatrice Balzarotti; Paola Marmiroli; Andrea Sbarbati; Guido Cavaletti; Stefano Pluchino; Pasquina Marzola
Journal:  J Neurosci       Date:  2015-07-08       Impact factor: 6.167

10.  Jacobian Mapping Reveals Converging Brain Substrates of Disruption and Repair in Response to Ethanol Exposure and Abstinence in 2 Strains of Rats.

Authors:  Qingyu Zhao; Kilian M Pohl; Edith V Sullivan; Adolf Pfefferbaum; Natalie M Zahr
Journal:  Alcohol Clin Exp Res       Date:  2020-11-20       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.